Sanjivani Paranteral Limited (BOM:531569)

Market Cap	2.21B -30.0%
Revenue (ttm)	736.34M +13.7%
Net Income	82.71M +15.4%
EPS	6.60 +19.3%
Shares Out	12.28M
PE Ratio	27.29
Forward PE	n/a
Dividend	0.50 (0.28%)
Ex-Dividend Date	n/a

Volume	6,379
Average Volume	17,297
Open	172.50
Previous Close	167.00
Day's Range	171.00 - 182.00
52-Week Range	132.50 - 268.80
Beta	-0.53
RSI	61.56
Earnings Date	May 8, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531569

Financial Performance

In fiscal year 2025, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.97 million, an increase of 31.34%.